Published in PLoS One on January 15, 2010
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature (2014) 5.51
Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol (2013) 4.34
Control of pathogens and pathobionts by the gut microbiota. Nat Immunol (2013) 2.84
Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun (2014) 2.39
Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility. Microbiome (2014) 1.82
Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid. J Bacteriol (2010) 1.82
Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology (2014) 1.77
Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol (2012) 1.70
Bile acid recognition by the Clostridium difficile germinant receptor, CspC, is important for establishing infection. PLoS Pathog (2013) 1.55
Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol (2013) 1.52
Germination of spores of Bacillus species: what we know and do not know. J Bacteriol (2014) 1.47
Importance of Glutamate Dehydrogenase (GDH) in Clostridium difficile Colonization In Vivo. PLoS One (2016) 1.40
Exit from dormancy in microbial organisms. Nat Rev Microbiol (2010) 1.35
From stool transplants to next-generation microbiota therapeutics. Gastroenterology (2014) 1.29
Structural and functional analysis of the CspB protease required for Clostridium spore germination. PLoS Pathog (2013) 1.19
Dynamics and establishment of Clostridium difficile infection in the murine gastrointestinal tract. Infect Immun (2014) 1.18
Models for the study of Clostridium difficile infection. Gut Microbes (2012) 1.16
Kinetic evidence for the presence of putative germination receptors in Clostridium difficile spores. J Bacteriol (2010) 1.12
Clostridium difficile and the microbiota. J Clin Invest (2014) 1.09
Current concepts of the intestinal microbiota and the pathogenesis of infection. Curr Infect Dis Rep (2011) 1.05
Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth. PLoS One (2016) 0.96
Immune responses to Clostridium difficile infection. Trends Mol Med (2012) 0.95
Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns. Mucosal Immunol (2014) 0.95
Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection. Gut Microbes (2013) 0.94
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile. Annu Rev Microbiol (2015) 0.93
Role of microbiota and innate immunity in recurrent Clostridium difficile infection. J Immunol Res (2014) 0.93
Gene-targeted microfluidic cultivation validated by isolation of a gut bacterium listed in Human Microbiome Project's Most Wanted taxa. Proc Natl Acad Sci U S A (2014) 0.92
Clostridium difficile infection: molecular pathogenesis and novel therapeutics. Expert Rev Anti Infect Ther (2014) 0.92
Identification of a Novel Lipoprotein Regulator of Clostridium difficile Spore Germination. PLoS Pathog (2015) 0.91
Cyclic di-GMP riboswitch-regulated type IV pili contribute to aggregation of Clostridium difficile. J Bacteriol (2014) 0.91
Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol (2016) 0.90
Contribution of spores to the ability of Clostridium difficile to adhere to surfaces. Appl Environ Microbiol (2012) 0.89
Progesterone analogs influence germination of Clostridium sordellii and Clostridium difficile spores in vitro. J Bacteriol (2011) 0.89
An in vitro culture model to study the dynamics of colonic microbiota in Syrian golden hamsters and their susceptibility to infection with Clostridium difficile. ISME J (2014) 0.84
Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic Resistance. Genes (Basel) (2015) 0.84
Clostridium difficile contains plasmalogen species of phospholipids and glycolipids. Biochim Biophys Acta (2014) 0.83
Humanized microbiota mice as a model of recurrent Clostridium difficile disease. Microbiome (2015) 0.82
Microbial bile acid metabolic clusters: the bouncers at the bar. Cell Host Microbe (2014) 0.82
Colonization Resistance of the Gut Microbiota against Clostridium difficile. Antibiotics (Basel) (2015) 0.82
Harnessing microbiota to kill a pathogen: Fixing the microbiota to treat Clostridium difficile infections. Nat Med (2014) 0.81
The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection. Mol Immunol (2014) 0.81
Fecal transplant policy and legislation. World J Gastroenterol (2015) 0.80
Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles. Aliment Pharmacol Ther (2016) 0.80
Ursodeoxycholic Acid Inhibits Clostridium difficile Spore Germination and Vegetative Growth, and Prevents the Recurrence of Ileal Pouchitis Associated With the Infection. J Clin Gastroenterol (2016) 0.79
When pathogenic bacteria meet the intestinal microbiota. Philos Trans R Soc Lond B Biol Sci (2016) 0.79
Cross-talk between bile acids and intestinal microbiota in host metabolism and health. J Zhejiang Univ Sci B (2015) 0.79
Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection. Anaerobe (2016) 0.79
Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clin Microbiol Rev (2017) 0.78
An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection. PLoS One (2016) 0.77
Gastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infection. World J Gastrointest Pathophysiol (2015) 0.76
The human microbiota: novel targets for hospital-acquired infections and antibiotic resistance. Ann Epidemiol (2016) 0.76
A Clostridium difficile-Specific, Gel-Forming Protein Required for Optimal Spore Germination. MBio (2017) 0.75
Bile acid sensitivity and in vivo virulence of clinical Clostridium difficile isolates. Anaerobe (2016) 0.75
Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract. Anaerobe (2016) 0.75
A Gut Odyssey: The Impact of the Microbiota on Clostridium difficile Spore Formation and Germination. PLoS Pathog (2015) 0.75
Survival of the Fittest: How Bacterial Pathogens Utilize Bile To Enhance Infection. Clin Microbiol Rev (2016) 0.75
Rapid change of fecal microbiome and disappearance of Clostridium difficile in a colonized infant after transition from breast milk to cow milk. Microbiome (2016) 0.75
Interaction of gut microbiota with bile acid metabolism and its influence on disease states. Appl Microbiol Biotechnol (2016) 0.75
Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea. Aliment Pharmacol Ther (2017) 0.75
Bile salt hydrolase-mediated inhibitory effect of Bacteroides ovatus on growth of Clostridium difficile. J Microbiol (2017) 0.75
The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet (2006) 8.02
Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun (2009) 7.48
Spore germination. Curr Opin Microbiol (2003) 6.02
Bile salt biotransformations by human intestinal bacteria. J Lipid Res (2005) 6.00
How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis (2006) 5.86
Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis (2005) 4.89
Colonization resistance. Antimicrob Agents Chemother (1994) 4.51
Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis (2005) 4.42
Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. J Clin Microbiol (1982) 4.35
The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol (2007) 4.09
A mouse model of Clostridium difficile-associated disease. Gastroenterology (2008) 3.65
Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol (2008) 3.37
Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun (2009) 3.36
Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology (2009) 3.29
Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun (1988) 3.11
Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of growth in mucus. Infect Immun (1988) 2.65
Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell Mol Life Sci (2008) 2.60
IscR-dependent gene expression links iron-sulphur cluster assembly to the control of O2-regulated genes in Escherichia coli. Mol Microbiol (2006) 2.26
Clostridium difficile in gnotobiotic mice. Infect Immun (1980) 2.17
Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination. J Clin Microbiol (1983) 2.15
Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clin Infect Dis (2008) 1.76
Clostridium difficile: emergence of hypervirulence and fluoroquinolone resistance. Infection (2007) 1.72
National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control (2009) 1.68
The challenges posed by reemerging Clostridium difficile infection. Clin Infect Dis (2007) 1.66
Chenodeoxycholate is an inhibitor of Clostridium difficile spore germination. J Bacteriol (2008) 1.53
The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med (2002) 1.50
Modulation of cytotoxin production by Clostridium difficile in the intestinal tracts of gnotobiotic mice inoculated with various human intestinal bacteria. Appl Environ Microbiol (1985) 1.47
Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice. Antimicrob Agents Chemother (2005) 1.40
The comparative pathology of Clostridium difficile-associated disease. Vet Pathol (2006) 1.26
Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins. J Infect Dis (1980) 1.24
Sulfate bile acids in germ-free and conventional mice. Eur J Biochem (1976) 1.14
Whole-bowel irrigation as an adjunct to the treatment of chronic, relapsing Clostridium difficile colitis. J Clin Gastroenterol (1996) 1.11
Clindamycin-induced colitis. Am J Clin Nutr (1979) 1.07
The influence of nonabsorbable antibiotics on serum lipids and the excretion of neutral sterols and bile acids. Am J Clin Nutr (1962) 0.93
Effect of neomycin and other antibiotics on serum cholesterol levels and on 7alpha-dehydroxylation of bile acids by the fecal bacterial flora in man. Circ Res (1973) 0.93
Examination of potential mechanisms to explain the association between proton pump inhibitors and Clostridium difficile infection. Antimicrob Agents Chemother (2009) 0.92
Susceptibility of hamsters to human pathogenic Clostridium difficile strain B1 following clindamycin, ampicillin or ceftriaxone administration. Anaerobe (2003) 0.92
Effects of beta-lactam antibiotics on intestinal microflora and bile acid metabolism in rats. Lipids (1996) 0.89
Orally administered beta-lactamase enzymes represent a novel strategy to prevent colonization by Clostridium difficile. J Antimicrob Chemother (2008) 0.87
Dehydroxylation of cholic acid at C12 and epimerization at C5 and C7 by Bacteroides species. J Steroid Biochem (1984) 0.85
Recent advances in Clostridium difficile-associated disease. Postgrad Med J (2009) 0.84
Intravenous immunoglobulin for resistant Clostridium difficile infection. Age Ageing (2005) 0.81
The role of anion-exchange resins in the treatment of antibiotic-associated pseudomembranous colitis. CMAJ (1990) 0.79
3 alpha-, 7 alpha-, and 12 alpha-OH group specific enzymic analysis of biliary bile acids: comparison with gas-liquid chromatograpy. J Lipid Res (1980) 0.78
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Genetics of gene expression and its effect on disease. Nature (2008) 21.35
Mapping the genetic architecture of gene expression in human liver. PLoS Biol (2008) 19.44
Variations in DNA elucidate molecular networks that cause disease. Nature (2008) 12.04
An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet (2005) 11.40
Apixaban in patients with atrial fibrillation. N Engl J Med (2011) 9.97
Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med (2011) 8.93
MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol Cell (2007) 5.67
Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med (2009) 4.83
Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat Cell Biol (2008) 4.68
A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet (2007) 4.46
Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell (2013) 4.45
Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol (2008) 3.37
Genetic heterogeneity of diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A (2013) 3.25
Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma. N Engl J Med (2015) 3.18
Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA (2007) 3.09
A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort. Genome Res (2011) 3.00
Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks. Nat Genet (2009) 2.97
Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation. Nat Med (2008) 2.85
BioMagResBank database with sets of experimental NMR constraints corresponding to the structures of over 1400 biomolecules deposited in the Protein Data Bank. J Biomol NMR (2003) 2.74
Additional targets of the Bacillus subtilis global regulator CodY identified by chromatin immunoprecipitation and genome-wide transcript analysis. J Bacteriol (2003) 2.65
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study. Circulation (2013) 2.64
China's facility-based birth strategy and neonatal mortality: a population-based epidemiological study. Lancet (2011) 2.64
Integrating QTL and high-density SNP analyses in mice to identify Insig2 as a susceptibility gene for plasma cholesterol levels. Genomics (2005) 2.61
QTLNetwork: mapping and visualizing genetic architecture of complex traits in experimental populations. Bioinformatics (2008) 2.57
CsrA and three redundant small RNAs regulate quorum sensing in Vibrio cholerae. Mol Microbiol (2005) 2.56
Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation. Stroke (2013) 2.52
Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat Genet (2010) 2.41
ToxR regulon of Vibrio cholerae and its expression in vibrios shed by cholera patients. Proc Natl Acad Sci U S A (2003) 2.29
Repression of Clostridium difficile toxin gene expression by CodY. Mol Microbiol (2007) 2.28
Mapping the genetic architecture of complex traits in experimental populations. Bioinformatics (2007) 2.27
Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol (2005) 2.21
Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood (2010) 2.15
A paired-end sequencing strategy to map the complex landscape of transcription initiation. Nat Methods (2010) 2.14
Detection of minor drug-resistant populations by parallel allele-specific sequencing. Nat Methods (2007) 2.09
Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res (2010) 2.06
Nuclear export and retention signals in the RS domain of SR proteins. Mol Cell Biol (2002) 2.04
Elucidating the murine brain transcriptional network in a segregating mouse population to identify core functional modules for obesity and diabetes. J Neurochem (2006) 2.00
Bidirectional control of social hierarchy by synaptic efficacy in medial prefrontal cortex. Science (2011) 1.97
Activation of the Bacillus subtilis global regulator CodY by direct interaction with branched-chain amino acids. Mol Microbiol (2004) 1.96
Staphylococcus aureus CodY negatively regulates virulence gene expression. J Bacteriol (2007) 1.88
Disentangling molecular relationships with a causal inference test. BMC Genet (2009) 1.84
A new Vibrio cholerae sRNA modulates colonization and affects release of outer membrane vesicles. Mol Microbiol (2008) 1.83
Genetic and phenotypic diversity of quorum-sensing systems in clinical and environmental isolates of Vibrio cholerae. Infect Immun (2006) 1.82
Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid. J Bacteriol (2010) 1.82
A Vibrio cholerae protease needed for killing of Caenorhabditis elegans has a role in protection from natural predator grazing. Proc Natl Acad Sci U S A (2006) 1.78
Multi-tissue coexpression networks reveal unexpected subnetworks associated with disease. Genome Biol (2009) 1.77
Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy. Mol Cancer Res (2011) 1.76
Direct targets of CodY in Staphylococcus aureus. J Bacteriol (2010) 1.76
Efficient sporulation in Clostridium difficile requires disruption of the sigmaK gene. Mol Microbiol (2003) 1.71
Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res (2011) 1.71
Characterization of relA and codY mutants of Listeria monocytogenes: identification of the CodY regulon and its role in virulence. Mol Microbiol (2007) 1.69
Long-range polony haplotyping of individual human chromosome molecules. Nat Genet (2006) 1.69
Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat Genet (2010) 1.69
PML nuclear bodies and apoptosis. Oncogene (2004) 1.66
A Bayesian partition method for detecting pleiotropic and epistatic eQTL modules. PLoS Comput Biol (2010) 1.66
Mucosal penetration primes Vibrio cholerae for host colonization by repressing quorum sensing. Proc Natl Acad Sci U S A (2008) 1.63
Transcription factor AtMYB103 is required for anther development by regulating tapetum development, callose dissolution and exine formation in Arabidopsis. Plant J (2007) 1.58
A combinatorial approach to detecting gene-gene and gene-environment interactions in family studies. Am J Hum Genet (2008) 1.57
Surface-plasmon-enhanced GaN-LED based on a multilayered M-shaped nano-grating. Opt Express (2013) 1.56
Bile acids stimulate biofilm formation in Vibrio cholerae. Mol Microbiol (2006) 1.56
Bile acid recognition by the Clostridium difficile germinant receptor, CspC, is important for establishing infection. PLoS Pathog (2013) 1.55
A splicing-independent function of SF2/ASF in microRNA processing. Mol Cell (2010) 1.55
The structure of CodY, a GTP- and isoleucine-responsive regulator of stationary phase and virulence in gram-positive bacteria. J Biol Chem (2006) 1.54
Association between green tea intake and coronary artery disease in a Chinese population. Circ J (2009) 1.54
RUPTURED POLLEN GRAIN1, a member of the MtN3/saliva gene family, is crucial for exine pattern formation and cell integrity of microspores in Arabidopsis. Plant Physiol (2008) 1.54
Environmental response and autoregulation of Clostridium difficile TxeR, a sigma factor for toxin gene expression. J Bacteriol (2002) 1.53
Chenodeoxycholate is an inhibitor of Clostridium difficile spore germination. J Bacteriol (2008) 1.53
Characterization of endogenous human promyelocytic leukemia isoforms. Cancer Res (2006) 1.52
Genetic and biochemical analysis of CodY-binding sites in Bacillus subtilis. J Bacteriol (2007) 1.50
A constitutively active variant of the quorum-sensing regulator LuxO affects protease production and biofilm formation in Vibrio cholerae. Infect Immun (2003) 1.50
Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors. J Biol Chem (2003) 1.49
Positive regulation of Bacillus subtilis ackA by CodY and CcpA: establishing a potential hierarchy in carbon flow. Mol Microbiol (2006) 1.47
Genome-wide interaction-based association analysis identified multiple new susceptibility Loci for common diseases. PLoS Genet (2011) 1.46
Ultrastructural evidence of mitochondrial abnormalities in postresuscitation myocardial dysfunction. Resuscitation (2011) 1.46
Interaction of Bacillus subtilis CodY with GTP. J Bacteriol (2007) 1.45
Prediabetes and short-term outcomes in nondiabetic patients after acute ST-elevation myocardial infarction. Cardiology (2013) 1.44
Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability. Microcirculation (2006) 1.44
Highly efficient extraction of serum peptides by ordered mesoporous carbon. Angew Chem Int Ed Engl (2011) 1.43
Integration of metabolism and virulence by Clostridium difficile CodY. J Bacteriol (2010) 1.43
Significance of 14-3-3 self-dimerization for phosphorylation-dependent target binding. Mol Biol Cell (2003) 1.42
Transcription initiation patterns indicate divergent strategies for gene regulation at the chromatin level. PLoS Genet (2011) 1.41
PfSETvs methylation of histone H3K36 represses virulence genes in Plasmodium falciparum. Nature (2013) 1.40
Lobelane analogues as novel ligands for the vesicular monoamine transporter-2. Bioorg Med Chem (2005) 1.38
Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents. Bioorg Med Chem Lett (2004) 1.36
The HcrVf2 gene from a wild apple confers scab resistance to a transgenic cultivated variety. Proc Natl Acad Sci U S A (2004) 1.32
Nitrogen-doped graphene: beyond single substitution and enhanced molecular sensing. Sci Rep (2012) 1.31
Construction of regulatory networks using expression time-series data of a genotyped population. Proc Natl Acad Sci U S A (2011) 1.31
Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry. Circulation (2014) 1.30
Bacillus subtilis ilvB operon: an intersection of global regulons. Mol Microbiol (2005) 1.30
Vibrio cholerae anaerobic induction of virulence gene expression is controlled by thiol-based switches of virulence regulator AphB. Proc Natl Acad Sci U S A (2010) 1.29
Vibrio cholerae virulence regulator-coordinated evasion of host immunity. Proc Natl Acad Sci U S A (2006) 1.29
Regulatory targets of quorum sensing in Vibrio cholerae: evidence for two distinct HapR-binding motifs. Nucleic Acids Res (2009) 1.28
A two-component system regulates the expression of an ABC transporter for xylo-oligosaccharides in Geobacillus stearothermophilus. Appl Environ Microbiol (2006) 1.28
Revised nomenclature of Clostridium difficile toxins and associated genes. J Med Microbiol (2005) 1.28